Ledger.Open graph →
SEC Form D · filed April 5, 2019

MINERVA BIOTECHNOLOGIES Corp

Offering
$12.0M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Kenneth A. Reed · Waltham, MADirectorKenneth Kosik · Waltham, MADirectorRobert Staszewski · Waltham, MADirectorNormand F. Smith · Waltham, MADirectorJames R. Bridges · Waltham, MADirectorCynthia Bamdad · Waltham, MAExec · DirectorJoseph A. Nathan · Waltham, MADirectorLawrence A. Coolidge · Waltham, MADirectorJames V. O'Donnell · Saint Louis, MODirectorRonald E. Osman · Saint Louis, MODirectorBrandon Jundt · Denver, COExec · DirectorTaylor Hobbs · Waco, TXDirectorLowell J. Burnett · San Diego, CADirectorBrent Eley · Bellevue, WADirectorMilton Pinsky · Northbrook, ILExec · DirectorBrad Sargent · Cupertino, CADirectorMichael Cassara · San Diego, CADirectorBenjamin Alfonsi · New York, NYDirectorMichael Skead · Vancouver, British Columbia, CanadaDirectorAndrew Rosen · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗